Palo Alto Health Sciences Names Amy Perry to Board of Directors

Danville, CA – (August 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® treatment for panic attacks and panic disorder, today announced that Amy Perry, CEO of the Hospital Division and Senior Vice President of Integrated Care delivery at...

Freespira® Clinical Data to be Presented at Three Upcoming Conferences

Danville, CA – (May 17, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of the Freespira® at-home treatment for panic attacks and panic disorder, today announced that newly-published clinical data will be presented at three professional conferences in May:...